SCLP Scancell Holdings plc

1.053USD80.00 GBp · LSE+1.27%Mkt Cap: 142.92M USDP/E: —

Scancell Holdings plc, a clinical stage biopharmaceutical company, discovers and develops of immunotherapies for the treatment of cancer in the United Kingdom. The company's product candidates include ImmunoBody, DNA act…